Editorial: Targeting tumor vasculature to enhance cancer immunotherapy

Bibliographic Details
Main Authors: Jieying Yang, Li Fu, Toshiro Shirakawa, Tong Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1199811/full
_version_ 1797844907159715840
author Jieying Yang
Li Fu
Toshiro Shirakawa
Toshiro Shirakawa
Tong Xiang
author_facet Jieying Yang
Li Fu
Toshiro Shirakawa
Toshiro Shirakawa
Tong Xiang
author_sort Jieying Yang
collection DOAJ
first_indexed 2024-04-09T17:29:57Z
format Article
id doaj.art-119c1161c1054dcdbd181e0a892dd828
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T17:29:57Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-119c1161c1054dcdbd181e0a892dd8282023-04-18T05:26:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-04-011310.3389/fonc.2023.11998111199811Editorial: Targeting tumor vasculature to enhance cancer immunotherapyJieying Yang0Li Fu1Toshiro Shirakawa2Toshiro Shirakawa3Tong Xiang4State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen International Cancer Centre, Shenzhen University School of Medicine, Shenzhen, ChinaDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, JapanDepartment of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe, JapanState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2023.1199811/fullcancer immunotherapytumor vascularizationvascular normalizationendothelial cell anergyimmunosuppressive molecules
spellingShingle Jieying Yang
Li Fu
Toshiro Shirakawa
Toshiro Shirakawa
Tong Xiang
Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
Frontiers in Oncology
cancer immunotherapy
tumor vascularization
vascular normalization
endothelial cell anergy
immunosuppressive molecules
title Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
title_full Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
title_fullStr Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
title_full_unstemmed Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
title_short Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
title_sort editorial targeting tumor vasculature to enhance cancer immunotherapy
topic cancer immunotherapy
tumor vascularization
vascular normalization
endothelial cell anergy
immunosuppressive molecules
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1199811/full
work_keys_str_mv AT jieyingyang editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy
AT lifu editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy
AT toshiroshirakawa editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy
AT toshiroshirakawa editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy
AT tongxiang editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy